Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison

Journal of Proteome Research

Volumn 16, Issue 2, 2017, Pages 933-944

  Leuthold, Patrick ^a,b   Schaeffeler, Elke ^a,b   Winter, Stefan ^a,b   Büttner, Florian ^a,b   Hofmann, Ute ^a,b   Mürdter, Thomas E ^a,b   Rausch, Steffen ^a,b,c   Sonntag, Denise ^d   Wahrheit, Judith ^d   Fend, Falko ^c   Hennenlotter, Jörg ^c   Bedke, Jens ^c   Schwab, Matthias ^a,b,c   Haag, Mathias ^a,b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d BIOCRATES LIFE SCIENCES AG   (Austria)

Author keywords

clear cell renal cell carcinoma (ccRCC); kidney cancer; LC MS; lipidomics; metabolomics; nontargeted metabolomics; platform comparison; Q TOF; targeted metabolomics; tissue metabolomics

Indexed keywords

ALCOHOL; ALPHA AMINO ACID; CARBOXYLIC ACID; CERAMIDE; CREATININE; DIACYLGLYCEROL; GLUTAMINE; GLYCOSPHINGOLIPID; HEXOSE; HIPPURIC ACID; LIPID; LYSOPHOSPHOLIPID; MANNITOL; MONOSACCHARIDE; NUCLEOSIDE DERIVATIVE; PANTOTHENIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PURINE DERIVATIVE; PYROGLUTAMIC ACID; SIALIC ACID; SORBITOL; SPHINGOMYELIN; SUGAR ALCOHOL; THIONEINE; TRIACYLGLYCEROL; TRIGONELLINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; KIDNEY CANCER; KIDNEY TISSUE; LIPIDOMICS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; PIG; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; STATISTICAL ANALYSIS; TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION PROCESS; ANIMAL; CARCINOMA, RENAL CELL; CHEMISTRY; COMPARATIVE STUDY; DEVICES; ISOLATION AND PURIFICATION; KIDNEY; KIDNEY NEOPLASMS; LIQUID CHROMATOGRAPHY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLOME; PATHOLOGY; PROCEDURES;

ANIMALS; CARCINOMA, RENAL CELL; CHROMATOGRAPHY, LIQUID; HUMANS; KIDNEY; KIDNEY NEOPLASMS; LIPIDS; METABOLOME; METABOLOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SWINE;

EID: 85011715964     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.6b00875     Document Type: Article

References (65)

1. Johnson, C. H.; Ivanisevic, J.; Siuzdak, G. Metabolomics: beyond biomarkers and towards mechanisms Nat. Rev. Mol. Cell Biol. 2016, 17 (7) 451-459 10.1038/nrm.2016.25
2. Cairns, R. A.; Harris, I. S.; Mak, T. W. Regulation of cancer cell metabolism Nat. Rev. Cancer 2011, 11 (2) 85-95 10.1038/nrc2981
3. Monteiro, M. S.; Carvalho, M.; de Lourdes Bastos, M.; de Pinho, P. G. Biomarkers in renal cell carcinoma: a metabolomics approach Metabolomics 2014, 10 (6) 1210-1222 10.1007/s11306-014-0659-5
4. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 2013, 499 (7456) 43-49 10.1038/nature12222
5. Fisel, P.; Kruck, S.; Winter, S.; Bedke, J.; Hennenlotter, J.; Nies, A. T.; Scharpf, M.; Fend, F.; Stenzl, A.; Schwab, M.; Schaeffeler, E. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome Clin. Cancer Res. 2013, 19 (18) 5170-5181 10.1158/1078-0432.CCR-13-1180
6. Hakimi, A. A.; Reznik, E.; Lee, C. H.; Creighton, C. J.; Brannon, A. R.; Luna, A.; Aksoy, B. A.; Liu, E. M.; Shen, R.; Lee, W.; Chen, Y.; Stirdivant, S. M.; Russo, P.; Chen, Y. B.; Tickoo, S. K.; Reuter, V. E.; Cheng, E. H.; Sander, C.; Hsieh, J. J. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma Cancer Cell 2016, 29 (1) 104-116 10.1016/j.ccell.2015.12.004
7. Hu, S. L.; Chang, A.; Perazella, M. A.; Okusa, M. D.; Jaimes, E. A.; Weiss, R. H. The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma J. Am. Soc. Nephrol. 2016, 27 (8) 2227-2237 10.1681/ASN.2015121335
8. Wettersten, H. I.; Hakimi, A. A.; Morin, D.; Bianchi, C.; Johnstone, M. E.; Donohoe, D. R.; Trott, J. F.; Aboud, O. A.; Stirdivant, S.; Neri, B.; Wolfert, R.; Stewart, B.; Perego, R.; Hsieh, J. J.; Weiss, R. H. Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis Cancer Res. 2015, 75 (12) 2541-2552 10.1158/0008-5472.CAN-14-1703
9. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Thun, M. J. Cancer statistics, 2007 Ca-Cancer J. Clin. 2007, 57 (1) 43-66 10.3322/canjclin.57.1.43
10. Moch, H.; Cubilla, A. L.; Humphrey, P. A.; Reuter, V. E.; Ulbright, T. M. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours Eur. Urol. 2016, 70 (1) 93-105 10.1016/j.eururo.2016.02.029
11. Shuch, B.; Amin, A.; Armstrong, A. J.; Eble, J. N.; Ficarra, V.; Lopez-Beltran, A.; Martignoni, G.; Rini, B. I.; Kutikov, A. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity Eur. Urol. 2015, 67 (1) 85-97 10.1016/j.eururo.2014.04.029
12. Büttner, F.; Winter, S.; Rausch, S.; Reustle, A.; Kruck, S.; Junker, K.; Stenzl, A.; Agaimy, A.; Hartmann, A.; Bedke, J.; Schwab, M.; Schaeffeler, E. Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron Eur. Urol. 2015, 68 (6) 1016-1020 10.1016/j.eururo.2015.05.045
13. Catchpole, G.; Platzer, A.; Weikert, C.; Kempkensteffen, C.; Johannsen, M.; Krause, H.; Jung, K.; Miller, K.; Willmitzer, L.; Selbig, J.; Weikert, S. Metabolic profiling reveals key metabolic features of renal cell carcinoma J. Cell. Mol. Med. 2011, 15 (1) 109-118 10.1111/j.1582-4934.2009.00939.x
14. Gao, H.; Dong, B.; Jia, J.; Zhu, H.; Diao, C.; Yan, Z.; Huang, Y.; Li, X. Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases J. Cancer Res. Clin. Oncol. 2012, 138 (5) 753-761 10.1007/s00432-011-1134-6
15. Cífková, E.; Holčapek, M.; Lísa, M.; Vrána, D.; Melichar, B.; Študent, V. Lipidomic differentiation between human kidney tumors and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2015, 1000, 14-21 10.1016/j.jchromb.2015.07.011
16. Yoshimura, K.; Chen, L. C.; Mandal, M. K.; Nakazawa, T.; Yu, Z.; Uchiyama, T.; Hori, H.; Tanabe, K.; Kubota, T.; Fujii, H.; Katoh, R.; Hiraoka, K.; Takeda, S. Analysis of renal cell carcinoma as a first step for developing mass spectrometry-based diagnostics J. Am. Soc. Mass Spectrom. 2012, 23 (10) 1741-1749 10.1007/s13361-012-0447-2
17. Dill, A. L.; Eberlin, L. S.; Zheng, C.; Costa, A. B.; Ifa, D. R.; Cheng, L.; Masterson, T. A.; Koch, M. O.; Vitek, O.; Cooks, R. G. Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry Anal. Bioanal. Chem. 2010, 398 (7-8) 2969-2978 10.1007/s00216-010-4259-6
18. Saito, K.; Arai, E.; Maekawa, K.; Ishikawa, M.; Fujimoto, H.; Taguchi, R.; Matsumoto, K.; Kanai, Y.; Saito, Y. Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma Sci. Rep. 2016, 6, 28932 10.1038/srep28932
19. Shim, E. H.; Livi, C. B.; Rakheja, D.; Tan, J.; Benson, D.; Parekh, V.; Kho, E. Y.; Ghosh, A. P.; Kirkman, R.; Velu, S.; Dutta, S.; Chenna, B.; Rea, S. L.; Mishur, R. J.; Li, Q.; Johnson-Pais, T. L.; Guo, L.; Bae, S.; Wei, S.; Block, K.; Sudarshan, S. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer Cancer Discovery 2014, 4 (11) 1290-1298 10.1158/2159-8290.CD-13-0696
20. Zira, A. N.; Theocharis, S. E.; Mitropoulos, D.; Migdalis, V.; Mikros, E. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool J. Proteome Res. 2010, 9 (8) 4038-4044 10.1021/pr100226m
21. Gao, H.; Dong, B.; Liu, X.; Xuan, H.; Huang, Y.; Lin, D. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis Anal. Chim. Acta 2008, 624 (2) 269-277 10.1016/j.aca.2008.06.051
22. Lin, L.; Yu, Q.; Yan, X.; Hang, W.; Zheng, J.; Xing, J.; Huang, B. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer Analyst 2010, 135 (11) 2970-2978 10.1039/c0an00265h
23. Lin, L.; Huang, Z.; Gao, Y.; Yan, X.; Xing, J.; Hang, W. LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery J. Proteome. Res. 2011, 10 (3) 1396-1405 10.1021/pr101161u
24. Kim, K.; Aronov, P.; Zakharkin, S. O.; Anderson, D.; Perroud, B.; Thompson, I. M.; Weiss, R. H. Urine metabolomics analysis for kidney cancer detection and biomarker discovery Mol. Cell. Proteomics 2009, 8 (3) 558-570 10.1074/mcp.M800165-MCP200
25. Kim, K.; Taylor, S. L.; Ganti, S.; Guo, L.; Osier, M. V.; Weiss, R. H. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer OMICS 2011, 15 (5) 293-303 10.1089/omi.2010.0094
26. Kind, T.; Tolstikov, V.; Fiehn, O.; Weiss, R. H. A comprehensive urinary metabolomic approach for identifying kidney cancerr Anal. Biochem. 2007, 363 (2) 185-195 10.1016/j.ab.2007.01.028
27. Perroud, B.; Lee, J.; Valkova, N.; Dhirapong, A.; Lin, P. Y.; Fiehn, O.; Kültz, D.; Weiss, R. H. Pathway analysis of kidney cancer using proteomics and metabolic profiling Mol. Cancer 2006, 5, 64 10.1186/1476-4598-5-64
28. Sundelin, J. P.; Ståhlman, M.; Lundqvist, A.; Levin, M.; Parini, P.; Johansson, M. E.; Borén, J. Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear-cell renal cell carcinoma PLoS One 2012, 7 (11) e48694 10.1371/journal.pone.0048694
29. Haag, M.; Schmidt, A.; Sachsenheimer, T.; Brügger, B. Quantification of Signaling Lipids by Nano-Electrospray Ionization Tandem Mass Spectrometry (Nano-ESI MS/MS) Metabolites 2012, 2 (1) 57-76 10.3390/metabo2010057
30. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat. Protoc. 2007, 2 (11) 2692-2703 10.1038/nprot.2007.376
31. Garcia-Canaveras, J. C.; Donato, M. T.; Castell, J. V.; Lahoz, A. A comprehensive untargeted metabonomic analysis of human steatotic liver tissue by RP and HILIC chromatography coupled to mass spectrometry reveals important metabolic alterations J. Proteome Res. 2011, 10 (10) 4825-4834 10.1021/pr200629p
32. Vorkas, P. A.; Isaac, G.; Anwar, M. A.; Davies, A. H.; Want, E. J.; Nicholson, J. K.; Holmes, E. Untargeted UPLC-MS profiling pipeline to expand tissue metabolome coverage: application to cardiovascular disease Anal. Chem. 2015, 87 (8) 4184-4193 10.1021/ac503775m
33. Haag, M.; Hofmann, U.; Mürdter, T. E.; Heinkele, G.; Leuthold, P.; Blank, A.; Haefeli, W. E.; Alexandrov, A.; Urban, S.; Schwab, M. Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na(+)-taurocholate cotransporting polypeptide inhibitor Anal. Bioanal. Chem. 2015, 407 (22) 6815-6825 10.1007/s00216-015-8853-5
34. Cajka, T.; Fiehn, O. Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics Anal. Chem. 2016, 88 (1) 524-545 10.1021/acs.analchem.5b04491
35. Ramsay, S. L.; Guggenbichler, W.; Weinberger, K. M.; Graber, A.; Stoeggl, W. M. Device for quantitative analysis of a metabolite profile. EP 1875401 B1, 2007.
36. Ramsay, S. L.; Stoeggl, W. M.; Weinberger, K. M.; Graber, A.; Guggenbichler, W. Apparatus and method for analyzing a metabolite profile. EP 1897014 B1, 2007.
37. Nkuipou-Kenfack, E.; Duranton, F.; Gayrard, N.; Àrgilés, A.; Lundin, U.; Weinberger, K. M.; Dakna, M.; Delles, C.; Mullen, W.; Husi, H.; Klein, J.; Koeck, T.; Zürbig, P.; Mischak, H. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease PLoS One 2014, 9 (5) e96955 10.1371/journal.pone.0096955
38. Fahy, E.; Sud, M.; Cotter, D.; Subramaniam, S. LIPID MAPS online tools for lipid research Nucleic Acids Res. 2007, 35, W606-W612 10.1093/nar/gkm324
39. Wishart, D. S.; Jewison, T.; Guo, A. C.; Wilson, M.; Knox, C.; Liu, Y.; Djoumbou, Y.; Mandal, R.; Aziat, F.; Dong, E.; Bouatra, S.; Sinelnikov, I.; Arndt, D.; Xia, J.; Liu, P.; Yallou, F.; Bjorndahl, T.; Perez-Pineiro, R.; Eisner, R.; Allen, F.; Neveu, V.; Greiner, R.; Scalbert, A. HMDB 3.0 - The Human Metabolome Database in 2013 Nucleic Acids Res. 2013, 41, D801-D807 10.1093/nar/gks1065
40. Smith, C. A.; O'Maille, G.; Want, E. J.; Qin, C.; Trauger, S. A.; Brandon, T. R.; Custodio, D. E.; Abagyan, R.; Siuzdak, G. METLIN: a metabolite mass spectral database Ther. Drug Monit. 2005, 27 (6) 747-751 10.1097/01.ftd.0000179845.53213.39
41. Horai, H.; Arita, M.; Kanaya, S.; Nihei, Y.; Ikeda, T.; Suwa, K.; Ojima, Y.; Tanaka, K.; Tanaka, S.; Aoshima, K.; Oda, Y.; Kakazu, Y.; Kusano, M.; Tohge, T.; Matsuda, F.; Sawada, Y.; Hirai, M. Y.; Nakanishi, H.; Ikeda, K.; Akimoto, N.; Maoka, T.; Takahashi, H.; Ara, T.; Sakurai, N.; Suzuki, H.; Shibata, D.; Neumann, S.; Iida, T.; Tanaka, K.; Funatsu, K.; Matsuura, F.; Soga, T.; Taguchi, R.; Saito, K.; Nishioka, T. MassBank: a public repository for sharing mass spectral data for life sciences J. Mass Spectrom. 2010, 45 (7) 703-714 10.1002/jms.1777
42. van der Hooft, J. J.; Ridder, L.; Barrett, M. P.; Burgess, K. E. Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines Front. Bioeng. Biotechnol. 2015, 3, 26 10.3389/fbioe.2015.00026
43. Godzien, J.; Ciborowski, M.; Martínez-Alcázar, M. P.; Samczuk, P.; Kretowski, A.; Barbas, C. Rapid and Reliable Identification of Phospholipids for Untargeted Metabolomics with LC-ESI-QTOF-MS/MS J. Proteome Res. 2015, 14 (8) 3204-3216 10.1021/acs.jproteome.5b00169
44. Murphy, R. C.; James, P. F.; McAnoy, A. M.; Krank, J.; Duchoslav, E.; Barkley, R. M. Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry Anal. Biochem. 2007, 366 (1) 59-70 10.1016/j.ab.2007.03.012
45. Zemski Berry, K. A.; Murphy, R. C. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids J. Am. Soc. Mass Spectrom. 2004, 15 (10) 1499-1508 10.1016/j.jasms.2004.07.009
46. Kirsch, S.; Müthing, J.; Peter-Katalinić, J.; Bindila, L. On-line nano-HPLC/ESI QTOF MS monitoring of alpha2-3 and alpha2-6 sialylation in granulocyte glycosphingolipidome Biol. Chem. 2009, 390 (7) 657-672 10.1515/BC.2009.066
47. Ito, E.; Waki, H.; Miseki, K.; Shimada, T.; Sato, T. A.; Kakehi, K.; Suzuki, M.; Suzuki, A. Structural characterization of neutral glycosphingolipids using high-performance liquid chromatography-electrospray ionization mass spectrometry with a repeated high-speed polarity and MSn switching system Glycoconjugate J. 2013, 30 (9) 881-888 10.1007/s10719-013-9492-8
48. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2014.
49. Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing J. R. Stat. Soc. Ser. B Stat. Methodol. 1995, 289-300
50. Xia, J.; Sinelnikov, I. V.; Han, B.; Wishart, D. S. MetaboAnalyst 3.0 - making metabolomics more meaningful Nucleic Acids Res. 2015, 43 (W1) W251-W257 10.1093/nar/gkv380
51. Emami, R. A.; Fisel, P.; Nies, A. T.; Schaeffeler, E.; Schwab, M. Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects Trends Pharmacol. Sci. 2013, 34 (2) 126-135 10.1016/j.tips.2012.11.005
52. Luo, P.; Dai, W.; Yin, P.; Zeng, Z.; Kong, H.; Zhou, L.; Wang, X.; Chen, S.; Lu, X.; Xu, G. Multiple reaction monitoring-ion pair finder: a systematic approach to transform nontargeted mode to pseudotargeted mode for metabolomics study based on liquid chromatography-mass spectrometry Anal. Chem. 2015, 87 (10) 5050-5055 10.1021/acs.analchem.5b00615
53. Contrepois, K.; Liang, L.; Snyder, M. Can Metabolic Profiles Be Used as a Phenotypic Readout of the Genome to Enhance Precision Medicine? Clin. Chem. 2016, 62 (5) 676-678 10.1373/clinchem.2015.251181
54. Contrepois, K.; Jiang, L.; Snyder, M. Optimized Analytical Procedures for the Untargeted Metabolomic Profiling of Human Urine and Plasma by Combining Hydrophilic Interaction (HILIC) and Reverse-Phase Liquid Chromatography (RPLC)-Mass Spectrometry Mol. Cell. Proteomics 2015, 14 (6) 1684-1695 10.1074/mcp.M114.046508
55. Sangster, T.; Major, H.; Plumb, R.; Wilson, A. J.; Wilson, I. D. A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis Analyst 2006, 131 (10) 1075-1078 10.1039/b604498k
56. Masson, P.; Alves, A. C.; Ebbels, T. M.; Nicholson, J. K.; Want, E. J. Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS Anal. Chem. 2010, 82 (18) 7779-7786 10.1021/ac101722e
57. Ivanisevic, J.; Zhu, Z. J.; Plate, L.; Tautenhahn, R.; Chen, S.; O'Brien, P. J.; Johnson, C. H.; Marletta, M. A.; Patti, G. J.; Siuzdak, G. Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism Anal. Chem. 2013, 85 (14) 6876-6884 10.1021/ac401140h
58. Luo, P.; Yin, P.; Zhang, W.; Zhou, L.; Lu, X.; Lin, X.; Xu, G. Optimization of large-scale pseudotargeted metabolomics method based on liquid chromatography-mass spectrometry J. Chromatogr., A 2016, 1437, 127-136 10.1016/j.chroma.2016.01.078
59. Ejigu, B. A.; Valkenborg, D.; Baggerman, G.; Vanaerschot, M.; Witters, E.; Dujardin, J. C.; Burzykowski, T.; Berg, M. Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomics profiling experiments OMICS 2013, 17 (9) 473-485 10.1089/omi.2013.0010
60. Yet, I.; Menni, C.; Shin, S. Y.; Mangino, M.; Soranzo, N.; Adamski, J.; Suhre, K.; Spector, T. D.; Kastenmüller, G.; Bell, J. T. Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms PLoS One 2016, 11 (4) e0153672 10.1371/journal.pone.0153672
61. Römisch-Margl, W.; Prehn, C.; Bogumil, R.; Röhring, C.; Suhre, K.; Adamski, J. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics Metabolomics 2012, 8 (1) 133-142 10.1007/s11306-011-0293-4
62. Suhre, K.; Meisinger, C.; Doring, A.; Altmaier, E.; Belcredi, P.; Gieger, C.; Chang, D.; Milburn, M. V.; Gall, W. E.; Weinberger, K. M.; Mewes, H. W.; Hrabe de, A. M.; Wichmann, H. E.; Kronenberg, F.; Adamski, J.; Illig, T. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting PLoS One 2010, 5 (11) e13953 10.1371/journal.pone.0013953
63. Savolainen, O. I.; Sandberg, A. S.; Ross, A. B. A Simultaneous Metabolic Profiling and Quantitative Multimetabolite Metabolomic Method for Human Plasma Using Gas-Chromatography Tandem Mass Spectrometry J. Proteome Res. 2016, 15 (1) 259-265 10.1021/acs.jproteome.5b00790
64. Michalak, K. P.; Maćkowska-Kedziora, A.; Sobolewski, B.; Woźniak, P. Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism Oxid. Med. Cell. Longevity 2015, 2015, 964321 10.1155/2015/964321
65. Ueno, S.; Saito, S.; Wada, T.; Yamaguchi, K.; Satoh, M.; Arai, Y.; Miyagi, T. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility J. Biol. Chem. 2006, 281 (12) 7756-7764 10.1074/jbc.M509668200